If recruitment and retention matter, site satisfaction must be treated as a prerequisite. In this Journal for Clinical Studies article, Brian Mallon explains why start-up success is shaped by human factors, not technolog...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
The effect of Covid-19 solutions on the clinical trials process
Shelley McLendon, VP of Project Management, Vaccines and Infectious Diseases, outlines best practices that can keep trials running at optimal speed and efficiency, and the benefits of adopting a strategic partnership.
-
-
The Irish Times Business Person of the Month: Steve Cutler
ICON CEO Steve Cutler has been chosen as The Irish Times Business Person of the Month for February 2021.
-
US Regulators question AstraZeneca vaccine trial data
ICON's Dr. Andrew Garrett, Executive Vice President of Scientific Operations, weighs in on potential safety issues with the AstraZeneca COVID-19 vaccine.
-
International Women's Day: An interview with Marelise Epstein
Marelise Epstein is interviewed for International Women's Day and provides a glimpse into her work day and what inspires her.
-
Steve Cutler: ‘People understand what a clinical trial is now’
An interview with CEO Steve Cutler on ICON's recent acquisition of PRA Health Sciences.
-
Mind the gap: Managed access programmes as an alternative to long-term follow up studies
Veronica Gutierrez Martinez and Michael Tokar discuss the challenges of setting up MAPs and the various considerations that must be tackled for a successful programme.
-
How COVID-19 has changed pharmacovigilance
Dr Andrew Garrett contributes to this article in Pharmafocus: How COVID-19 has changed pharmacovigilance. The article explores how drug safety can be ensured while numerous vaccines and treatments come to market in record time to deal with COVID-19.
-
How scientists John Climax and Dr Ronan Lambe created an icon
An article reporting on the growth of ICON as it acquires PRA Health Sciences.
-
